Acadian Asset Management Portfolio holdings
AUM
$60.9B
1-Year Est. Return
33.57%
This Fund
S&P 500
1 Year Est. Return
+33.57%
AUM
$57.3B
AUM Growth
+$8.85B
(+18%)
Holding
2,055
Top Buys
| 1 | +$726M | |
| 2 | +$616M | |
| 3 | +$593M | |
| 4 |
JPMorgan Chase
JPM
|
+$436M |
| 5 |
Meta Platforms (Facebook)
META
|
+$426M |
Top Sells
| 1 | +$275M | |
| 2 | +$261M | |
| 3 | +$247M | |
| 4 |
PepsiCo
PEP
|
+$240M |
| 5 |
Visa
V
|
+$176M |
Sector Composition
| 1 | Technology | 34.07% |
| 2 | Financials | 16.49% |
| 3 | Communication Services | 13.53% |
| 4 | Healthcare | 10.53% |
| 5 | Consumer Discretionary | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNDK
951
Sandisk
SNDK
$93.8B
| $1.55M | ﹤0.01% |
13,888
-8,267
|
|
||
952
Nektar Therapeutics
NKTR
$2.06B
| $1.55M | ﹤0.01% |
27,335
-393,623
|
|
||
953
eHealth
EHTH
$40.1M
| $1.54M | ﹤0.01% |
358,435
-226,495
|
|
||
954
Mettler-Toledo International
MTD
$25.5B
| $1.54M | ﹤0.01% |
1,253
-1,570
|
|
||
955
American Well
AMWL
$87.1M
| $1.53M | ﹤0.01% |
249,698
+59,112
|
|
||
956
Twin Disc
TWIN
$217M
| $1.51M | ﹤0.01% |
108,599
+22,539
|
|
||
957
Exelixis
EXEL
$11.1B
| $1.51M | ﹤0.01% |
36,549
-303,215
|
|
||
958
Monte Rosa Therapeutics
GLUE
$1.32B
| $1.51M | ﹤0.01% |
203,550
+157,408
|
|
||
959
Nomad Foods
NOMD
$1.37B
| $1.5M | ﹤0.01% |
114,207
-171,468
|
|
||
960
Eversource Energy
ES
$26B
| $1.5M | ﹤0.01% |
21,077
+20,381
|
|
||
961
Best Buy
BBY
$13.4B
| $1.49M | ﹤0.01% |
19,714
+602
|
|
||
962
PTC Therapeutics
PTCT
$5.64B
| $1.48M | ﹤0.01% |
24,150
-103,643
|
|
||
|
ALEX
963
DELISTED
Alexander & Baldwin
ALEX
| $1.47M | ﹤0.01% |
81,118
+60,308
|
|
||
964
AngioDynamics
ANGO
$469M
| $1.47M | ﹤0.01% |
+131,593
|
|
||
965
Viant Technology
DSP
$199M
| $1.46M | ﹤0.01% |
168,990
+19,179
|
|
||
966
MYR Group
MYRG
$4.39B
| $1.44M | ﹤0.01% |
6,923
+3,944
|
|
||
967
Visteon
VC
$2.44B
| $1.44M | ﹤0.01% |
+12,026
|
|
||
968
Arhaus
ARHS
$957M
| $1.43M | ﹤0.01% |
+134,460
|
|
||
|
BELFB
969
Bel Fuse Inc Class B
BELFB
$2.51B
| $1.42M | ﹤0.01% |
10,084
-14,565
|
|
||
970
Dave Inc
DAVE
$2.31B
| $1.42M | ﹤0.01% |
7,124
-34,589
|
|
||
|
ABVX
971
Abivax
ABVX
$8.82B
| $1.41M | ﹤0.01% |
+16,608
|
|
||
972
Outset Medical
OM
$70.3M
| $1.41M | ﹤0.01% |
99,963
+75,622
|
|
||
973
Allegro MicroSystems
ALGM
$5.84B
| $1.4M | ﹤0.01% |
+48,240
|
|
||
974
GeneDx Holdings
WGS
$1.88B
| $1.4M | ﹤0.01% |
+13,060
|
|
||
975
Acadia Pharmaceuticals
ACAD
$3.8B
| $1.39M | ﹤0.01% |
+65,383
|
|